Sustiva (efavirenz)

WITHDRAWN · PHASE2 · HIV Infection, Hepatitis C

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.